BHT's potential to cause cancer is unclear, with conflicting evidence from animal and human studies. The IARC classifies BHT as not classifiable as to its carcinogenicity to humans, requiring further research.
The potential for BHT to cause cancer is a complex issue with conflicting evidence. Some animal studies have suggested a link between high doses of BHT and certain cancers, while others have indicated protective effects. Human studies are inconclusive, and the IARC has classified BHT as Group 3: Not classifiable as to its carcinogenicity to humans. Further research is needed to determine the true cancer risk in humans at typical exposure levels.
Key Information
Severity
Medium
Associated Ingredients
1 ingredient
Associated Ingredients
Important Safety Information
This information is for educational purposes only. Always consult with a healthcare professional before starting any new supplement regimen, especially if you experience any side effects.